- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05448898
The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction
July 7, 2022 updated by: Eye & ENT Hospital of Fudan University
The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction: A Randomized Controlled Trial
Studies have demonstrated that patients with olfactory dysfunction could improve the olfactory function after olfactory training.
But the efficacy of Traditional Chinese Medicine is unknown.The purpose of this study is to evaluate its efficacy in olfactory dysfunction.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
A recent meta-analysis found significant positive effects of olfactory training on the individual subcomponents of odor threshold, discrimination, identification, and the composite TDI score.
In addition to the evidenced improvement in olfactory function after olfactory training, this form of treatment carries very little risk of adverse effects, is cheap, and can be administered by the patient.
For these collective reasons, olfactory training is an attractive treatment modality.
Chinese experts consensus on diagnosis and treatment of olfactory dysfunction in 2017 shown that some evidences proved that Traditional Chinese Medicine treatment would benefit olfactory dysfunction but the evidences is not adequate.
Until now, the efficacy of Traditional Chinese Medicine is controversial.
This study investigate the efficacy and the safety of Traditional Chinese Medicine and olfactory training as a treatment for patients with olfactory dysfunction.
Study Type
Interventional
Enrollment (Anticipated)
278
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hongmeng Yu, Dr
- Phone Number: 13501730576
- Email: hongmengyush@163.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200031
- Recruiting
- Eye & ENT Hospital
-
Contact:
- Hongmeng Yu, Dr
- Phone Number: 13501730576
- Email: hongmengyush@fudan.edu.cn
-
Principal Investigator:
- YanQing Li, Dr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Olfactory dysfunction;
- 18 ≤ age ≤ 55 years old;
- No active infection, such as uncontrolled pneumonia;
- Women with reproductive potential and sexually active men agree to use acceptable and effective contraceptive methods.
Exclusion Criteria:
- Refuse to sign informed consent;
- With other diseases that affect the result, such as severe hepatic and renal dysfunction and the investigators believes will interfere with the treatment;
- Pregnant or lactating women;
- Without personal freedom and independent civil capacity;
- Enrolled in other intervention clinical trials;
- Autoimmune diseases;
- Other situations that the investigators think are not suitable for the trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Traditional Chinese Medicine with olfactory training
Traditional Chinese Medicine therapy: Oral Traditional Chinese Medicine CU Xiu Tang once a day for at least 3 months Olfactory training: repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months |
Oral Traditional Chinese Medicine CU Xiu Tang once a day and repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months
Other Names:
repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months
|
|
Experimental: Olfactory training
repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months
|
repeat and deliberate sniffing of a set of odorants for 20 seconds each at least twice a day for at least 3 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Olfactory function test result
Time Frame: 3 months
|
Olfactory tests combination of odor threshold (T), odor discrimination (D), and odor identification (I).
The minimum values is 0, the maximum values of odor threshold (T), discrimination (D), and identification (I) is 16, the sum of the scores is TDI, which is between 0 to 48, the higher scores mean a better outcome.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Odor threshold (T), Odor Discrimination (D), Odor Identification (I)
Time Frame: 3 months
|
The scale of odor threshold (T), discrimination (D), and identification (I).The minimum values is 0, the maximum values of odor threshold (T), discrimination (D), and identification (I) is 16, the higher scores mean a better outcome.
|
3 months
|
|
the Visual Analogue Scale(VAS) of Olfactory Function
Time Frame: 3 months
|
Participants should value their olfactory function by use the Visual Analogue Scale#VAS), the minimum values is 0, the maximum values is 10, the higher scores mean a better outcome.
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire of Olfactory Disorders
Time Frame: 3 months
|
every patients should answer the Questionnaire of Olfactory Disorders and record the results.
The answers should be agreed, Partially agreed and disagreed.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: YanQing Li, Dr, Eye & ENT Hospital, Fudan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 15, 2022
Primary Completion (Anticipated)
November 30, 2023
Study Completion (Anticipated)
December 30, 2023
Study Registration Dates
First Submitted
July 4, 2022
First Submitted That Met QC Criteria
July 4, 2022
First Posted (Actual)
July 8, 2022
Study Record Updates
Last Update Posted (Actual)
July 11, 2022
Last Update Submitted That Met QC Criteria
July 7, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ODCT2002-6
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Olfactory Disorder
-
St. Paul's Hospital, CanadaRecruitingOlfactory DisorderCanada
-
University of Kansas Medical CenterCompleted
-
University of WashingtonCompleted
-
University of BernUniversity of Zurich; Swiss National Science Foundation; University of Lausanne; University of Geneva, Switzerland and other collaboratorsCompletedSmoking Cessation | Olfactory DisorderSwitzerland
-
Centre Hospitalier Universitaire de NiceCompletedPatients Without an Olfactory DisorderFrance
-
Washington University School of MedicineCompletedOlfactory DisorderUnited States
-
Stanford UniversityUniversity of California, San DiegoCompletedCovid19 | Olfactory Nerve Diseases | Olfaction Disorders | Olfactory Disorder | Olfactory Nerve Injuries | Olfactory Nerve Disorder | Post-Viral DisorderUnited States
-
Peking University Third HospitalRecruitingOlfactory Dysfunction | Post Viral Olfactory Dysfunction (PVOD)China
-
Cliniques universitaires Saint-Luc- Université...CompletedFrailty | Perioperative/Postoperative Complications | Olfactory DisorderBelgium
-
Northwestern UniversityRecruitingHuman Olfactory Amygdala FunctionUnited States
Clinical Trials on Traditional Chinese Medicine CU Xiu Tang
-
Peking University Third HospitalNot yet recruiting
-
Henan University of Traditional Chinese MedicineThe First Affiliated Hospital of Zhengzhou University; China-Japan Friendship... and other collaboratorsNot yet recruiting
-
Peking Union Medical College HospitalGuangdong Provincial Hospital of Traditional Chinese Medicine; Peking University... and other collaboratorsRecruitingFunctional Hypothalamic AmenorrheaChina
-
Peking Union Medical College HospitalShandong University; Guangdong Provincial Hospital of Traditional Chinese Medicine and other collaboratorsNot yet recruitingInfertility | Diminished Ovarian Reserve (DOR)China
-
Henan University of Traditional Chinese MedicineUnknownCommunity-acquired PneumoniaChina
-
Qianfoshan HospitalNot yet recruitingHepatic Encephalopathy | Cirrhosis, Liver | Portosystemic ShuntChina
-
Chung Shan Medical UniversityCompletedGynecological Disorders
-
Xiyuan Hospital of China Academy of Chinese Medical...Beijing Municipal Science & Technology CommissionUnknownAdvanced Colorectal Cancer | Traditional Chinese MedicineChina
-
Henan University of Traditional Chinese MedicineNot yet recruitingCommunity-Acquired InfectionsChina
-
Shengjing HospitalRecruitingPlasma Cell MastitisChina